Biotech | February 13, 2021
Biocon Biologics and Viatris receive European Commission approval for Kixelle, Biosimilar Insulin Aspart
The centralized marketing authorization granted by the EC is valid in all EU Member
The centralized marketing authorization granted by the EC is valid in all EU Member
The Department has been working continuously to ensure a stable long-term policy environment and reduce the compliance burden on the Industry.
WACKER and Helixmith plan to strategically collaborate on the production of a pDNA gene therapy developed by Helixmith for the treatment of diabetic peripheral neuropathy (DPN).
The commercial production in the SML was started in November 1989.
Subscribe To Our Newsletter & Stay Updated
